(Q51698609)

10 April 2018

title

Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. (English)

1 reference

10 April 2018

1 reference

1

1 reference

10 April 2018

author name string

David J Johnson

2

1 reference

10 April 2018

Tamara Reitsma

3

1 reference

10 April 2018

Richard A Brain

4

1 reference

10 April 2018

Christian J Wilson

5

1 reference

10 April 2018

Keith R Solomon

6

1 reference

10 April 2018

language of work or name

English

0 references

publication date

1 April 2004

1 reference

10 April 2018

Regulatory Toxicology and Pharmacology

published in

1 reference

10 April 2018

volume

39

1 reference

10 April 2018

issue

2

1 reference

10 April 2018

page(s)

158-183

1 reference

10 April 2018

Mixture toxicity and its modeling by quantitative structure-activity relationships

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Prioritisation of veterinary medicines in the UK environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Are veterinary medicines causing environmental risks?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Overview of data and conceptual approaches for derivation of quantitative structure-activity relationships for ecotoxicological effects of organic chemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Pharmaceuticals in the environment--a human risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Fugacity analysis and model of organic chemical fate in a sewage treatment plant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Pharmaceuticals and personal care products in the environment: agents of subtle change?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Cradle-to-cradle stewardship of drugs for minimizing their environmental disposition while promoting human health. I. Rationale for and avenues toward a green pharmacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Proof of causality: deduction from epidemiological observation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

QSARs promote more efficient use of chemical testing resources--carpe diem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Modes of action in ecotoxicology: their role in body burdens, species sensitivity, QSARs, and mixture effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Occurrence, fate and effects of pharmaceutical substances in the environment--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Occurrence of antibiotics in the aquatic environment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Human pharmaceuticals in the aquatic environment a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Aquatic environmental assessment of the top 25 English prescription pharmaceuticals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

7 January 2021

Drugs in the environment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources--a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Aquatic persistence of eight pharmaceuticals in a microcosm study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

The exposure assessment for veterinary medicinal products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

A comparison of model performance for six quantitative structure-activity relationship packages that predict acute toxicity to fish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Identification and significance of phenazone drugs and their metabolites in ground- and drinking water

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Ecotoxicity prediction using mechanism- and non-mechanism-based QSARs: a preliminary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

The fate of pharmaceutical chemicals in the aquatic environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

A framework for prioritizing fragrance materials for aquatic risk assessment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Power analysis as a reflexive scientific tool for interpretation and implementation of the precautionary principle in the European Union.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Quantitative structure-activity relationship models for prediction of estrogen receptor binding affinity of structurally diverse chemicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Pharmacodynamic activity of drugs and ecotoxicology--can the two be connected?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

U.S. EPA regulatory perspectives on the use of QSAR for new and existing chemical evaluations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2003.12.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YRTPH.2003.12.006

1 reference

10 April 2018

PubMed ID

15041147

1 reference

10 April 2018